A R T I C L E S
Mallena et al.
shown that some polyamide-benzimidazole hybrid compounds
can recognize long base pair sequences of DNA in a 1:1
complex.13 Armitage and co-workers have made the exciting
discovery that selectively designed cyanine dyes can stack as
dimers in the minor groove in AT sequences to form a tandem
helical array that has the potential to generate new nanomate-
rials.14 For the heterocyclic diamidines described above, the
DNA complexes of DB75 and the related furan-benzimidazole
derivative DB293 (Figure 1) have been thoroughly studied and
they display many interesting, useful and quite different
properties.1,3,15,16 Both compounds bind strongly as monomer
complexes in the DNA minor groove in AT sequences of at
least four base pairs in length. Both have a significant
hydrophobic energetic component in formation of their AT
complexes but also depend on other energetic terms such as
van der Waals, electrostatic and H-bonding to drive complex
formation.17,18 DB75 binds much more strongly to AT rich
sequences than pentamidine and, because of the fact that many
parasitic microorganisms have AT rich DNA, the AT binding
appears to be correlated with their biological activity.1 DB75
is an important compound because of its therapeutic properties
but it is essential to develop additional compounds in case of
drug resistance as well as to develop compounds with activities
against other organisms. Compounds that exploit the nature of
the AT rich DNAs in both the nucleus and particularly in the
kinetoplast of organisms such as trypanosomes are of particular
interest.
DB293 is also one of the most exciting new minor groove
binding compounds discovered recently since it can form a
unique dimer structure that stacks in an antiparallel arrangement
in the minor groove to recognize sites that contain GC as well
as AT base pairs.1,15,16,18 In addition to its classical binding
monomer binding mode in AT sequences, this compound offers
an entirely new dimer interaction mode for sequence specific
recognition of mixed DNA sequences. Since it is readily taken
up into cells,19 it obviously offers unique opportunities to
develop new types of sequence-selective DNA targeted thera-
peutic agents. For these reasons, we are engaged in a series of
synthetic, biological, and biophysical studies to understand the
DNA complexes of these compounds in detail and to use this
information to design new compounds with additional and
improved therapeutic and DNA recognition abilities. As part
of this effort, thiophene derivatives with amidine cationic groups
(Figure 1), which are directly related to DB75 and DB293, have
been prepared and their DNA complexes characterized with a
broad array of different methods including X-ray determination
of a complex structure with DB818 bound at an AATT minor
groove site. We show in this paper that although the thiophene
derivatives differ by only a single atom from the parent furans,
they have significant shape changes that can make a large
difference in DNA complex formation depending on the other
groups in the molecular system and their interactions with DNA.
Materials and Methods
Buffers and Oligonucleotides. The double stranded polymers
poly(dAT)2 and poly(dGC)2 were purchased from Pharmacia
(U. S.), and were used in UV-Vis titration experiments. In
Biacore and CD experiments three 5′-biotin labeled hairpin
duplexes namely d(Biotin-CGAATTCGTCTCCGAATTCG)
(AATT hairpin), d(Biotin-CATATATA CCCCTATATATG)
(AT hairpin), d(Biotin-CGCGCGC TTTTGCGCGCG) (Figure
1) were purchased with HPLC purification (Midland Certified
Reagent Co., Midland, TX). The MES buffer used in these
experiments contained 0.010 M [2-(N-morpholino) ethane-
sulfonic acid] (MES), 0.001 M EDTA, 0.1 M NaCl, pH 6.25.
Compound Synthesis: 2-{2-[5(6)-Amidino]benzimidazolyl}-
5-[(4-amidino)phenyl] thiophene trihydrochloride (DB818,
Figure 1). A solution of potassium carbonate (4.4 g, 0.32 mole)
in 10 mL water was added to a stirred solution of 5-bromo-2-
(dimethoxymethyl)thiophene19 (3.3 g, 0.014 mole), 4-cy-
anophenylboronic acid (2.35 g, 0.016 mole) in 35 mL dioxane,
under nitrogen, and stirring was continued for 15 min. After
addition of Pd (PPh3)4 (0.32 g, 2mole%) the mixture was heated
at reflux for 8 h (TLC monitored), cooled, diluted with water
and extracted with 2 × 35 mL chloroform. The chloroform layer
was washed with water and stirred with 20% HCl (40 mL) for
35 min. The organic layer was washed with water, 5% sodium
bicarbonate, water, brine, and dried over sodium sulfate, passed
through a bed of silica, dried and the solvent reduced to yield
5-(4-cyanophenyl)-2-thiophene carboxaldehyde as a white solid
(12) Lacy, E. R.; Madsen, E. M.; Lee, M.; Wilson, W. D. In Small Molecule
DNA and RNA Binders; Demeunynck, M., Bailly, C., Wilson, W. D., Eds.;
Wiley-VCH: 2003; Vol. 2, pp 384-413.
(13) (a) Reddy, P. M.; Jindra, P. T.; Satz, A. L.; Bruice, T. C. J. Am. Chem.
Soc. 2003, 125, 7843-8. (b) Satz, A. L.; Bruice, T. C. Acc. Chem. Res.
2002, 35, 86.
(14) (a) Garoff, R. A.; Litzinger, E. A.; Connor, R. E.; Irene, F.; Armitage, B.
A. Langmuir 2002, 18, 6330-6337. (b) Wang, M.; Silva, G. L.; Armitage,
B. A. J. Am. Chem. Soc. 2000, 122, 9977-9986.
(15) (a) Tanious, F. A.; Hemmelberg, D.; Bailly, C.; Czarny, A.; Boykin, D.
W.; Wilson, W. D. J. Am. Chem. Soc. 2004, 126, 143-153. (b) Nguyen,
B.; Hammelberg, D.; Bailly, C.; Colson, P.; Stanek, J.; Brun, R.; Neidle,
S.; Wilson, W. D. Biophys. J. 2004, 86, 1028-1041. (c) Trent, J. O.; Clark,
G. R.; Kumar, A.; Wilson, W. D.; Boykin, D. W.; Hall, J. E.; Tidwell, R.
R.; Blagburn, B. L.; Neidle, S. J. Med. Chem. 1996, 39, 4554-4562.
(16) (a) Wang, L.; Bailly, C.; Kumar, A.; Ding, D.; Bajic, M.; Boykin, D. W.;
Wilson, W. D. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 12-16. (b) Wang,
L.; Carrasco, C.; Kumar, A.; Stephens, C. E.; Bailly, C.; Boykin, D. W.;
Wilson, W. D. Biochemistry 2001, 40, 2511-2521. (c) Nguyen, B.; Tardy,
C.; Bailly, C.; Colson, P.; Houssier, C.; Kumar, A.; Boykin, D. W.; Wilson,
W. D. Biopolymers 2002, 63, 281-297. (d) Tanious, F. A.; Wilson, W.
D.; Wang, Lei.; Kumar, A.; Boykin, D. W.; Marty, C.; Baldeyrou, B.; Bailly,
C. Biochemistry 2003, 46, 13576-13586. (e) Bailly, C.; Tardy, C.; Wang,
L.; Armitage, B.; Hopkins, K.; Kumar, A.; Schuster, G. B.; Boykin, D.
W.; Wilson, W. D. Biochemistry 2001, 40, 9770-9779. (f) Bailly, C.;
Dassonneville, L.; Carrosco, C.; Lucas, D.; Kumar, A.; Boykin, D. W.;
Wilson, W. D. Anti-Cancer Drug Des. 1999, 14, 47-60.
1
2.35 g (77%), mp 208-210 °C dec, H NMR (DMSO-d6): δ
9.95 (s, 1H), 8.06 (d, 1H, J ) 4 Hz), 7.98 (d, 2H, J ) 8.8 Hz),
7.91 (d, 1H, J ) 8.8 Hz), 7.88 (d, 1H, J ) 4 Hz); 13C NMR
(DMSO-d6): δ 184.0, 149.6, 143.5, 138.4, 136.5, 133.0, 127.2,
126.7, 118.0, 111.4; MS: m/e 213 (M+). Anal. Calcd. for
C12H7NOS: C, 67.58; H, 3.30; N, 6.56. Found: C, 67.31; H,
3.41; N, 6.44.
A mixture of the thiophene aldehyde (2.13 g, 0.01 mol), 3,4-
diaminobenzonitrile (1.33 g, 0.01 mol) and 1,4-benzoquinone
(1.08 g, 0.01 mol) in 50 mL dry ethanol was heated under reflux
(N2 atmos.) for 8 h, cooled, diluted with ether, and filtered. The
solid was collected and stirred with 1:3 mixture of EtOH and
ether for 20 min., filtered, washed with ether, and vacuum-dried
at 70 °C for 12 h to yield 2.10 g (60%) of the yellow
(17) Mazur, S.; Tanious, F. A.; Ding, D.; Kumar, A.; Boykin, D. W.; Simpson,
J. J.; Neidle, S.; Wilson, W. D. J. Mol. Biol. 2000, 300, 321-337.
(18) (a) Wang, L.; Kumar, A.; Boykin, D. W.; Bailly, C.; Wilson, W. D. J.
Mol. Biol. 2002, 317, 361-374. (b) Lansiaux, A. L.; Tanious, F.; Mishal,
Z.; Dassonneville, L.; Kumar, A.; Stephens, C. E.; Hu, Q.; Wilson, W. D.;
Boykin, D. W.; Bailly, C. Cancer Res. 2002, 62, 7219-7229.
(19) (a) Lansiaux, A. L.; Dassonneville, L.; Faxompre, M.; Kumar, A.; Stephans,
C. E.; Bajic, M.; Tanious, F. A.; Wilson, W. D.; Boykin, D. W.; Bailly, C.
J. Med. Chem. 2002, 45, 1994-2002. (b) Lansiaux, A.; Tanious, F. A.;
Mishal, Z.; Dassonneville, L.; Kumar, A.; Stephens, C. E.; Hu, O.; Wilson,
W. D.; Boykin, D. W.; Bailly, C. Cancer Res. 2000, 62, 7219-7229.
9
13660 J. AM. CHEM. SOC. VOL. 126, NO. 42, 2004